Rachel Levenbach in Moorestown, New Jersey

Medical School: Temple University School Of Medicine
Graduation Year: 2008
The Primary Medical Specialty for Rachel Levenbach is listed as: Hematology/oncology
Approximate Years of Experience: 16
PAC (PECOS ID)#: 0749427722
NPI #: 1902065857
NPI Created On: 06/05/2008
NPI Last Updated Listed as: 10/19/2021
Primary Taxonomy Code: 207RX0202X
License Number:
25MA09521700
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• Humana
• Oscar Garden State Insurance Corporation
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
4. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
5. Infusion of chemotherapy into a vein up to 1 hour
6. Infusion of chemotherapy into a vein
7. New patient office or other outpatient visit, typically 30 minutes
8. New patient office or other outpatient visit, typically 45 minutes
9. Established patient office or other outpatient visit, typically 10 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Initial hospital inpatient care, typically 30 minutes per day
13. Initial hospital inpatient care, typically 50 minutes per day
14. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
15. Injection, epoetin alfa, (for non-esrd use), 1000 units
16. Injection, dexamethasone sodium phosphate, 1 mg
17. Injection, diphenhydramine hcl, up to 50 mg
18. Injection, ferric carboxymaltose, 1 mg
19. Injection, palonosetron hcl, 25 mcg
20. Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).